Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
---|---|---|---|---|---|---|
Boston Scientific CorpBSX | $73.26 | Strong Buy | $85.00 | +16.03% | a day ago | |
Analyst RankingTop 7% #299 out of 4565 analysts Average Return+6.54% Win Rate59%114 out of 193 Risk vs RewardPoor Good Analyst ColorCitigroup's Joanne Wuensch raised their price target on Boston Scientific (NYSE: BSX) by 7.6% from $79 to $85 on 2024/04/26. The analyst maintained their Strong Buy rating on the stock. Wuensch's price target hike followed an assessment of Boston Scientific's 2024/04/24-dated Q1 2024 earnings report and participation in the earnings call. The analyst told investors that the company surpassed profitability, revenue, and key segment targets, leading to an increased FY 2024 outlook from management. Earnings ReportFor Q1 2024, Boston Scientific reported:
Management guided: For Q2 2024:
For FY 2024:
Chairman & CEO Mike Mahoney commented: "Our exceptional results this quarter were fueled by our talented global team and the strength of our diversified businesses and pipeline, including the initial U.S. launch of the FARAPULSE™ Pulsed Field Ablation System. "We continue to invest for the long term in our innovative portfolio and clinical science to benefit patients globally while delivering differentiated financial performance." | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | 2 days ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have a premium account? Sign In |